OPKO Health Inc OPK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
Trading Information
- Previous Close Price
- $1.67
- Day Range
- $1.67–1.70
- 52-Week Range
- $0.98–1.85
- Bid/Ask
- $1.64 / $2.02
- Shares Outstanding
- 742.51M
- Market Cap
- $1.25B
- Volume/Avg
- 2M / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 3.38%
Company Profile
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,275
- Website
- https://www.opko.com
Valuation
Metric | OPK |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.11 |
Price/Sales | 3.56 |
Price/Cash Flow | — |
Price/Earnings
OPK
Financial Strength
Metric | OPK |
|---|---|
Quick Ratio | 2.99 |
Current Ratio | 4.97 |
Interest Coverage | −1.57 |
Quick Ratio
OPK
Profitability
Metric | OPK |
|---|---|
Return on Assets (Normalized) | −10.43% |
Return on Equity (Normalized) | −16.29% |
Return on Invested Capital (Normalized) | −10.12% |
Return on Assets
OPK
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|>!YLCv% | LOCK|w^ | $259B | |||
| Danaher Corp DHR | LOCK|mtKLB?d | LOCK|@$@ | $163B | |||
| IDEXX Laboratories Inc IDXX | LOCK|x$y>z#Y& | LOCK|&f | $55B | |||
| Agilent Technologies Inc A | LOCK|Gd#H@TH | LOCK|@# | $49B | |||
| Waters Corp WAT | LOCK|mypK&T | LOCK|dj | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|zrsvB^c | LOCK|jY%k | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|?%#&<CF? | LOCK|zG$? | $34B | |||
| Illumina Inc ILMN | LOCK|l@M>c<Q | LOCK|thW!k | $32B | |||
| Labcorp Holdings Inc LH | LOCK|g>$!Dsj | LOCK|pSWN | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|j&Zrb^> | LOCK|&nd< | $29B |
United States